Not yet recruiting
Hormone-dependent prostate cancer+3
Not yet recruitingBMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI
InvestigationalNo placebo
BMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI
InvestigationalNo placebo
- Disease:Hormone-dependent prostate cancerProstate cancer metastatic+2
- Substances:BMS-986365
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:BMS-986365
- Sponsor:AIO-Studien gGmbH
